Artwork

Content provided by Dr. Joel Kahn. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr. Joel Kahn or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

How to Beat Your Appetite: The Science of Bitters Hops

23:43
 
Share
 

Manage episode 397033832 series 2884269
Content provided by Dr. Joel Kahn. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr. Joel Kahn or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Dive into an enthralling new episode at the Kahn Center this week, where Dr. Joel Kahn delves into groundbreaking research on Lipoprotein(a). He reveals that, particle for particle, it's significantly more atherogenic than LDL-cholesterol. However, given the higher prevalence of LDL-C particles, focusing on reducing LDL-C remains crucial. Next, Dr. Kahn explores an intriguing study on using high doses of vitamin K2 and D3 to slow down coronary artery calcification.

The episode's highlight is the exciting research on a New Zealand-based product, Calocurb, and its potential to reduce appetite and calorie intake. This discovery is particularly noteworthy as the mechanism mirrors that of injectable drugs like Wegovy and Mounjaro, but Calocurb is available as an affordable oral capsule. Dr. Kahn shares his personal experiences with Calocurb, detailing its impact on his mealtime routines.

Plus, listeners can enjoy a special offer – use the discount code 'Joel10' for savings on their purchase. Discover how Calocurb has been effectively integrated into fasting programs, enhancing their success.

  continue reading

377 episodes

Artwork
iconShare
 
Manage episode 397033832 series 2884269
Content provided by Dr. Joel Kahn. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr. Joel Kahn or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Dive into an enthralling new episode at the Kahn Center this week, where Dr. Joel Kahn delves into groundbreaking research on Lipoprotein(a). He reveals that, particle for particle, it's significantly more atherogenic than LDL-cholesterol. However, given the higher prevalence of LDL-C particles, focusing on reducing LDL-C remains crucial. Next, Dr. Kahn explores an intriguing study on using high doses of vitamin K2 and D3 to slow down coronary artery calcification.

The episode's highlight is the exciting research on a New Zealand-based product, Calocurb, and its potential to reduce appetite and calorie intake. This discovery is particularly noteworthy as the mechanism mirrors that of injectable drugs like Wegovy and Mounjaro, but Calocurb is available as an affordable oral capsule. Dr. Kahn shares his personal experiences with Calocurb, detailing its impact on his mealtime routines.

Plus, listeners can enjoy a special offer – use the discount code 'Joel10' for savings on their purchase. Discover how Calocurb has been effectively integrated into fasting programs, enhancing their success.

  continue reading

377 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide